RxDoctor Payments DataLook up a doctor →

Enzi Abebe, APRN

Gerontology · Las Vegas, NVNPI 1497102214

Payments from drug & device makers

$9,822in general payments, 2019–2025

Across 344 payments — averaging $28.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$2K
  • Melinta Therapeutics, LLC$2K
  • AbbVie$2K
  • Merck$865
  • Shionogi Inc$687
  • Merz North America, Inc.$568
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$9,64598%
  • Education$1782%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,822 in reported general payments places this provider in the 95th percentile of 72 gerontology providers in Nevada.

See all gerontology providers in Nevada

Medicare billing

Part B allowed, 2024
$1,453,464
Medicare patients
87
Services billed
1,598

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala93$381,044
CabenuvaCabotegravir/Rilpivirine18$122,203
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf24$118,407
GenvoyaElviteg/Cob/Emtri/Tenof Alafen24$91,766
OdefseyEmtricitab/Rilpiviri/Tenof Ala18$69,568
TivicayDolutegravir Sodium12$25,464
Daptomycin16$23,693
Fosfomycin Tromethamine32$7,412
Cefpodoxime Proxetil22$2,155
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav34$2,148
Gentamicin Sulfate25$1,060
Ciprofloxacin Hcl67$600
Levofloxacin23$293
Doxycycline Hyclate13$211
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim44$182

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy, Genvoya$468$472,811117 claims
Viiv Healthcare CompanyCabenuva, Tivicay$1,957$147,66730 claims
Janssen Products, LPSymtuza$165$118,40724 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 72 gerontology providers in Nevada.

Other gerontology in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →